SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001140361-23-045870
Filing Date
2023-09-29
Accepted
2023-09-29 09:10:54
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A ef20011463_sc14d9a.htm SC 14D9/A 17393
2 EXHIBIT 99.(A)(5)(M) ef20011463_ex99-a5m.htm EX-99.(A)(5)(M) 42971
3 arrow.jpg GRAPHIC 1039
4 logo.jpg GRAPHIC 26367
  Complete submission text file 0001140361-23-045870.txt   100149
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filed by) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Subject) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-88971 | Film No.: 231292284
SIC: 2834 Pharmaceutical Preparations